A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency.
Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force.
Speiser
Phyllis W
PW
Division of Pediatric Endocrinology, Cohen Children's Medical Center of New York, Hofstra University School of Medicine, 400 Lakeville Rd., Suite 180, New Hyde Park, NY 11040, USA.
Azziz
Ricardo
R
Baskin
Laurence S
LS
Ghizzoni
Lucia
L
Hensle
Terry W
TW
Merke
Deborah P
DP
Meyer-Bahlburg
Heino F L
HF
Miller
Walter L
WL
Montori
Victor M
VM
Oberfield
Sharon E
SE
Ritzen
Martin
M
White
Perrin C
PC